NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
6.93
+0.16 (2.36%)
Oct 9, 2026, 4:00 PM EDT - Market closed
NeurAxis Revenue
NeurAxis had revenue of $1.93M in the quarter ending June 30, 2026, with 115.72% growth. This brings the company's revenue in the last twelve months to $5.32M, up 65.22% year-over-year. In the year 2025, NeurAxis had annual revenue of $3.57M with 32.89% growth. That makes NeurAxis the 39,733rd largest company in the world by revenue and 5,279th in the United States.
Revenue (ttm)
$5.32M
Revenue Growth
+65.22%
P/S Ratio
16.37
Revenue / Employee
$221,505
Employees
24
Market Cap
87.03M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.57M | 883.36K | 32.89% |
| Dec 31, 2024 | 2.69M | 225.88K | 9.18% |
| Dec 31, 2023 | 2.46M | -224.69K | -8.37% |
| Dec 31, 2022 | 2.68M | -36.55K | -1.34% |
| Dec 31, 2021 | 2.72M | 791.06K | 40.98% |
| Dec 31, 2020 | 1.93M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Pelthos Therapeutics | 43.30M |
| ImmuCell | 30.68M |
| Equillium | 4.39M |
| Rallybio | 646.00K |
| Cardiff Oncology | 508.00K |
NRXS News
- 12 days ago - NeurAxis Transcript: Lytham Partners Fall 2026 Investor Conference - Transcripts
- 12 days ago - Neuraxis appoints Blanchard as Chief Commercial Officer - TheFly
- 12 days ago - NeurAxis Positions for Next Phase of Commercial Growth with Appointment of Craig Blanchard as Chief Commercial Officer - GlobeNewsWire
- 25 days ago - NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives - GlobeNewsWire
- 25 days ago - NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference - GlobeNewsWire
- 26 days ago - NeurAxis Transcript: IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 - Transcripts
- 2 months ago - NeurAxis Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - NeurAxis Quarterly report: Q2 2026 - Filings